Impact of COVID-19 pandemic on diabetes: a cross-sectional study at urban health centre in Goa
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20220258Keywords:
Diabetes mellitus, COVID-19, Pandemic, Effect, CommunityAbstract
Background: Diabetes is an important comorbidity which is contributing to the mortality among COVID-19 patients. There are limited studies in Goa which have measured the impact of COVID-19 on the diabetes. Therefore, this study is undertaken to measure the impact of lockdown on glycaemic control in patients with T2DM. The study objectives were to assess the changes in HbA1c and to identify some factors affecting the glycaemic control during the pandemic on the urban population of Goa during the period of pandemic.
Methods: A cross-sectional comparative study was undertaken during August to September 2020 amongst Diabetic patients undergoing treatment at Santa Cruz (Goa). Data was collected via oral questionnaire and from patients records at 6 months before and after lockdown after IEC approval. The data was entered into excel v2010, and analysed using SPSS v22 and expressed as simple proportion and percentages.
Results: Out of total 50 patients enrolled in the study, the mean post-lockdown HbA1c (8.2±2.1) was found to be higher as compared to pre-lockdown values (7.3±1.3) and the difference was statistically significant (p<0.05). The Chi Square test was calculated comparing HbA1c after lockdown with Diet, exercise and drug compliance which was found to be statistically significant (p<0.05).
Conclusions: Mean HbA1c of 50 T2DM patients was higher post lockdown. There is a need to re enforce necessary lifestyle modification and prescribed drug compliance for adequate diabetes control during COVID-19 pandemic to reduce overall morbidity.
Metrics
References
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-33.
Lu R, Zhao X, Li J, Niu P, Yang B, Wu H. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet. 2020;395(10224):565-74.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497-506.
Eberle C, Stichling S. Impact of COVID-19 lockdown on glycemic control in patients with type 1 and type 2 diabetes mellitus: a systematic review. Diabetol Metab Syndr. 2021;13(1):95.
Naous E, Boulos M, Sleilaty G, Achkar AA, Gannagé-Yared M-H. Quality of life and other patient-reported outcomes in adult Lebanese patients with type 2 diabetes during COVID-19 pandemic. J Endocrinol Invest. 2021;1-10.
Gupta R, Ghosh A, Singh AK, Misra A. Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes Metab Syndr Clin Res Rev. 2020;14(3):211-2.
Sites.pitt.edu. 2021. Available at: https://sites.pitt.edu/~super1/Metabolic/IDF5.pdf. Accessed on October 2, 2021.
Viigimaa M, Sachinidis A, Toumpourleka M, Koutsampasopoulos K, Alliksoo S, Titma T. Macrovascular Complications of Type 2 Diabetes Mellitus. Curr Vasc Pharmacol. 2020;18(2):110-6.
Scott ES, Jenkins AJ, Fulcher GR. Challenges of diabetes management during the COVID ‐19 pandemic. Med J Aust. 2020;213(2):56.
Tornese G, Ceconi V, Monasta L, Carletti C, Faleschini E, Barbi E. Glycemic Control in Type 1 Diabetes Mellitus During COVID-19 Quarantine and the Role of In-Home Physical Activity. Diabetes Technol Ther. 2020;22(6):462-7.
Bonora BM, Boscari F, Avogaro A, Bruttomesso D, Fadini GP. Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy. Diabetes Ther Res Treat Educ Diabetes Relat Disord. 2020;1-11.
Pla B, Arranz A, Knott C, Sampedro M, Jiménez S, Hernando I et al. Impact of COVID-19 Lockdown on Glycemic Control in Adults with Type 1 Diabetes Mellitus. J Endocr Soc. 2020;4(12):bvaa149.
Mathiyalagen P, Davis P, Sarasveni M. Updated BG Prasad Socio-Economic Classification: The 2020 Update. Indian J Pediatr. 2021;88(1):76-7.
Fonseca VA, Smith H, Kuhadiya N, Leger SM, Yau CL, Reynolds K. Impact of a natural disaster on diabetes. Diabetes Care. 2009;32:1632-8.
Kirizuka K, Nishizaki H, Kohriyama K, Nukata O, Arioka Y, Motobuchi M. Influences of the Great Hanshin-Awaji earthquake on glycemic control in diabetic patients. Diabetes Res Clin Pract. 1997;36(3):193-6.
Ghosh A, Arora B, Gupta R, Anoop S, Misra A. Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India. Diab Metab Syndrome. 2020;14(5):917-20.
Ruiz-Roso MB, Knott-Torcal C, Matilla-Escalante DC, Garcimartín A, Sampedro-Nuñez MA, Dávalos A et al. COVID-19 Lockdown and Changes of the Dietary Pattern and Physical Activity Habits in a Cohort of Patients with Type 2 Diabetes Mellitus. Nutrients. 2020;12(8):2327.
Sankar P, Ahmed WN, Mariam Koshy V, Jacob R, Sasidharan S. Effects of COVID-19 lockdown on type 2 diabetes, lifestyle and psychosocial health: A hospital-based cross-sectional survey from South India. Diabetes Metab Syndr. 2020;14(6):1815-9.
